GNC sale to China-based Harbin Pharmaceutical for $770 million approved by bankruptcy judge
September 18, 2020 at 08:30 AM EDT
U.S. Bankruptcy Court for the District of Delaware Judge Karen B. Owens authorized the transaction and praised lawyers on both sides of the negotiating table for pitching an uncontested sale.
